Claudio Traversi
Papers
1
Total Citations
136
H-Index
1
About
Dr. Claudio Traversi is a leading ophthalmologist and researcher whose work has significantly advanced the field of corneal crosslinking (CXL) for keratoconus treatment. His primary research focus lies in optimizing CXL protocols, particularly through the development and clinical validation of accelerated crosslinking techniques. Dr. Traversi’s most cited study, a prospective comparative analysis of pulsed versus continuous light accelerated crosslinking (2014, 136 citations), provided critical one-year outcome data demonstrating that pulsed-light protocols can achieve comparable corneal stiffening with potentially improved safety profiles by allowing oxygen diffusion. This landmark work directly addressed the clinical need for faster, more comfortable procedures without compromising efficacy. Beyond this, his contributions have helped shape modern CXL practice, with his research influencing how surgeons balance treatment speed, riboflavin formulations, and UV irradiation parameters. Dr. Traversi’s work has been instrumental in moving CXL from standard protocols to more patient-friendly accelerated regimens, earning him recognition as a key innovator in refractive surgery and corneal biomechanics. His findings continue to guide clinical decision-making for thousands of keratoconus patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1